NCT04044352View on ClinicalTrials.gov

H1N1v Virus Challenge Study in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

October 22, 2019

Primary Completion Date

March 2, 2020

Study Completion Date

March 2, 2020

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza A/Bethesda/MM2/H1N1 Challenge

Reverse-genetics derived live A/California/04/2009/H1N1-like influenza virus passaged six times in Vero cells.

Trial Locations (4)

27704

Duke Human Vaccine Institute - Duke Vaccine and Trials Unit, Durham

21201-1509

University of Maryland Baltimore - School of Medicine - Medicine, Baltimore

63104-1015

Saint Louis University - Center for Vaccine Development, St Louis

45229-3039

Cincinnati Children's Hospital Medical Center - Infectious Diseases, Cincinnati

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT04044352 - H1N1v Virus Challenge Study in Healthy Subjects | Biotech Hunter | Biotech Hunter